ATE504591T1 - Neue phosphorhaltige heterocyclische verbindungen,zuckeranaloga und zusammensetzungen mit antikrebswirkung, die diese enthalten - Google Patents
Neue phosphorhaltige heterocyclische verbindungen,zuckeranaloga und zusammensetzungen mit antikrebswirkung, die diese enthaltenInfo
- Publication number
- ATE504591T1 ATE504591T1 AT08774839T AT08774839T ATE504591T1 AT E504591 T1 ATE504591 T1 AT E504591T1 AT 08774839 T AT08774839 T AT 08774839T AT 08774839 T AT08774839 T AT 08774839T AT E504591 T1 ATE504591 T1 AT E504591T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- heterocyclic compounds
- cancer activity
- novel phosphorus
- sugar analogues
- Prior art date
Links
- 230000001093 anti-cancer Effects 0.000 title abstract 2
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657172—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and one oxygen atom being part of a (thio)phosphinic acid ester: (X = O, S)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94814307P | 2007-07-05 | 2007-07-05 | |
| PCT/EP2008/058788 WO2009004096A1 (en) | 2007-07-05 | 2008-07-07 | New phosphorus containing heterocyclic compounds, sugar analogues, and compositions having anti-cancer activity containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE504591T1 true ATE504591T1 (de) | 2011-04-15 |
Family
ID=39790257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08774839T ATE504591T1 (de) | 2007-07-05 | 2008-07-07 | Neue phosphorhaltige heterocyclische verbindungen,zuckeranaloga und zusammensetzungen mit antikrebswirkung, die diese enthalten |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8383609B2 (de) |
| EP (1) | EP2170912B3 (de) |
| AT (1) | ATE504591T1 (de) |
| DE (1) | DE602008006081D1 (de) |
| WO (1) | WO2009004096A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3002451B1 (fr) * | 2013-02-25 | 2015-06-26 | Centre Nat Rech Scient | Heterocycles phosphores analogues de sucres a activite antimetastatique |
| FR3050732B1 (fr) * | 2016-05-02 | 2019-06-28 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Nouveaux derives de phosphinolactones et leurs utilisations pharmaceutiques |
| EP3295944A1 (de) * | 2016-09-20 | 2018-03-21 | Phost'in | Kristalline polymorphe form von 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2lambda5-[1,2]oxaphosphinan |
| EP4277633A1 (de) * | 2021-01-13 | 2023-11-22 | Phost'in Therapeutics | Cyclische oxaphosphinanverbindungen und analoga davon zur behandlung fibrotischer erkrankungen |
| JP2025517432A (ja) | 2022-05-20 | 2025-06-05 | フォスティン・セラピューティクス | 複素環ホスフィン化合物のための投与量及びレジメン |
| WO2025132992A1 (en) | 2023-12-20 | 2025-06-26 | Phost'in Therapeutics | DEUTERATED DERIVATIVES OF 3-HYDROXY-4,5-BIS-BENZYLOXY-6-BENZYLOXYMETHYL-2-PHENYL-2-OXO-2λ5-[1,2]OXAPHOSPHINANE |
| WO2025160705A1 (zh) * | 2024-01-29 | 2025-08-07 | 维眸生物科技(浙江)有限公司 | 一种lfa-1抑制剂的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998031697A1 (en) * | 1997-01-15 | 1998-07-23 | Sankyo Company, Limited | Aryl c-glycoside compounds and sulfated esters thereof |
| PH12000002657B1 (en) | 1999-10-12 | 2006-02-21 | Bristol Myers Squibb Co | C-aryl glucoside SGLT2 inhibitors |
-
2008
- 2008-07-07 DE DE602008006081T patent/DE602008006081D1/de active Active
- 2008-07-07 AT AT08774839T patent/ATE504591T1/de not_active IP Right Cessation
- 2008-07-07 US US12/667,798 patent/US8383609B2/en active Active
- 2008-07-07 EP EP08774839.8A patent/EP2170912B3/de active Active
- 2008-07-07 WO PCT/EP2008/058788 patent/WO2009004096A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE602008006081D1 (de) | 2011-05-19 |
| EP2170912A1 (de) | 2010-04-07 |
| US20100298272A1 (en) | 2010-11-25 |
| EP2170912B3 (de) | 2022-06-15 |
| EP2170912B1 (de) | 2011-04-06 |
| US8383609B2 (en) | 2013-02-26 |
| WO2009004096A1 (en) | 2009-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE504591T1 (de) | Neue phosphorhaltige heterocyclische verbindungen,zuckeranaloga und zusammensetzungen mit antikrebswirkung, die diese enthalten | |
| TR201907575T4 (tr) | Hayvan parazitlerini kontrol etmeye yönelik faydalı ajanlar olarak aminobenzamid türevleri. | |
| UA111579C2 (uk) | ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ | |
| EA021275B9 (ru) | Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания | |
| MX2013011086A (es) | (aralquilamino y heteroarilalquilamino alfa-sustituidos)pirimidini lo y 1,3,5-triazinilbenzimidazoles, composiciones farmacéuticas que los contienen, y estos compuestos para su uso en el tratamiento de enfermedades proliferativas. | |
| BRPI0610850A2 (pt) | derivados de Ácido aril alquila, composiÇço farmacÊutica, medicamento, bem como uso dos referidos derivados | |
| CY1108794T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| EA201070841A1 (ru) | НОВЫЕ ПИРАЗОЛО[3,4-d]ПИРИМИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ПРОТИВОРАКОВЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
| UY30282A1 (es) | Compuestos quimicos | |
| TW200510392A (en) | Chemical compounds | |
| EA201101706A1 (ru) | Лекарственное средство на основе дииндолилметана(dim) с повышенной биодоступностью и его использование в лечении гиперпластических и воспалительных заболеваний человека | |
| TNSN07419A1 (en) | Methods for treating drug resistant cancer | |
| DE602008003404D1 (de) | 5,6,7,8-tetrahydropteridin-derivate als hsp90-hemmer | |
| TW200505452A (en) | Chemical compounds | |
| EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
| CY1112191T1 (el) | Παραγωγο πυραζολοπυριμιδινης | |
| WO2018005794A3 (en) | Novel non-systemic tgr5 agonists | |
| BRPI0407968A (pt) | derivados de oxamida úteis como inibidores de raf-quinase | |
| HRP20140215T1 (hr) | Kombinacija koja sadrži paklitaksel za lijeäśenje raka jajnika | |
| CO6180495A2 (es) | Formulacion de medicamento liquida | |
| BRPI0715609A2 (pt) | Composto, uso de um composto, métodos para produzir um efeito antiproliferativo em um animal de sangue quente, e para tratar uma doença em um animal de sangue quente, e, composição farmacêutica | |
| MX2009005912A (es) | Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos. | |
| CY1111361T1 (el) | Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια | |
| GB0412019D0 (en) | Organic compounds | |
| ATE451385T1 (de) | Verbindungen zur inhibierung von apoptose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |